- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Condyloma acuminatum.
Displaying page 1 of 1.
| EudraCT Number: 2008-004893-42 | Sponsor Protocol Number: 1.0 | Start Date*: 2008-10-15 | ||||||||||||||||
| Sponsor Name:Medizinische Universität Wien, Universitätsklinik für dermatologie | ||||||||||||||||||
| Full Title: | ||||||||||||||||||
| Medical condition: Condyloma accuminata, Vulvar Intraepithelial Neoplasia | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: AT (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2005-000162-40 | Sponsor Protocol Number: IFN 001 | Start Date*: 2005-09-06 |
| Sponsor Name:Helix Product Development (Ireland) Limited | ||
| Full Title: Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled study | ||
| Medical condition: Condylomata acuminata (genital warts) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004465-24 | Sponsor Protocol Number: EXP-1167 | Start Date*: 2015-02-18 | |||||||||||
| Sponsor Name:LEO Pharma A/S | |||||||||||||
| Full Title: Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts | |||||||||||||
| Medical condition: Anogenital warts | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-002455-20 | Sponsor Protocol Number: P150957 | Start Date*: 2016-11-18 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Efficacy study of the quadrivalent Human Papilloma Virus (HPV) vaccine to prevent recurrence of External Genital Warts (EGW) in patients who were cured in the first place | |||||||||||||
| Medical condition: Patients whose EGW have just disappeared after initial success of classic treatment | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-004007-13 | Sponsor Protocol Number: NCT-2010-1090 | Start Date*: 2013-09-06 | |||||||||||
| Sponsor Name:Deutsches Krebsforschungszentrum (DKFZ | |||||||||||||
| Full Title: A randomized, placebo-controlled, phase IIIb HPV vaccination trial with Gardasil® in patients with recurrent condylomata acuminata | |||||||||||||
| Medical condition: Patients with recurrrent external condylomata acuminata located at the following genital regions: labia minora and majora, introitus vaginae, clitoris, prepuce, glans penis, coronal sulcus and fren... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-005553-13 | Sponsor Protocol Number: CLS001-CO-PR-011 | Start Date*: 2016-05-11 | |||||||||||
| Sponsor Name:Cutanea Life Sciences | |||||||||||||
| Full Title: A PHASE 2, RANDOMIZED, VEHICLE-CONTROLLED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EXPLORE THE PHARMACODYNAMICS, SAFETY AND EFFICACY OF TOPICAL OMIGANAN IN PATIENTS WITH EXTERNAL GENITAL WARTS | |||||||||||||
| Medical condition: Patients with external genital warts | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-000870-39 | Sponsor Protocol Number: CHDR1607 | Start Date*: 2017-08-21 | ||||||||||||||||
| Sponsor Name:Cutanea Life Sciences | ||||||||||||||||||
| Full Title: A phase 2, randomized, vehicle-controlled, double-blind study to explore the efficacy, pharmacodynamics and safety of topical ionic contra-viral therapy (ICVT) comprised of digoxin and furosemide i... | ||||||||||||||||||
| Medical condition: HPV-induced genital lesions of immunocompromised and immunocompetent patients | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.